Compliance Rate

Compliance Rate 51.23%
Compliant submissions 187
Incompliant submissions 178
Total trials 365

My Organizations' Clinical Trials

Showing 1600 of 2400 entries
View as:

CD40L Antagonism in Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT05306353 Org: User:
Start: 07/25/23 End: 04/06/29 Due: 04/06/30

Mucosal and Systemic Immunity After Viral Challenge of Healthy Volunteers Vaccinated With Inactivated Influenza Vaccine Via the Intranasal Versus Intramuscular Route

Phase: N/A Priority: Normal
NCT ID: NCT03845231 Org: User:
Start: 04/29/19 End: 10/28/20 Due: 10/28/21

Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART

Phase: N/A Priority: Normal
NCT ID: NCT00270205 Org: User:
Start: 01/31/06 End: 09/30/10 Due: 09/30/11

Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals

Phase: N/A Priority: Normal
NCT ID: NCT00001080 Org: User:
Start: - End: - Due: -

Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected Adults

Phase: N/A Priority: Normal
NCT ID: NCT02296541 Org: User:
Start: 12/31/14 End: 07/06/20 Due: 07/06/21

The Role of Gut Microbiome in Predicting Comorbidities and Complications in Children With Inflammatory Bowel Disease

Phase: N/A Priority: Normal
NCT ID: NCT05652491 Org: User:
Start: 12/09/22 End: 05/30/23 Due: 05/30/24

Adaptive COVID-19 Treatment Trial 4 (ACTT-4)

Phase: N/A Priority: Normal
NCT ID: NCT04640168 Org: User:
Start: 12/02/20 End: 06/18/21 Due: 06/18/22

Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV

Phase: N/A Priority: Normal
NCT ID: NCT00001119 Org: User:
Start: 10/31/99 End: - Due: -

Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00005762 Org: User:
Start: 03/31/01 End: 05/31/04 Due: 05/31/05

Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis

Phase: N/A Priority: Normal
NCT ID: NCT00001646 Org: User:
Start: 08/31/97 End: 08/31/00 Due: 08/31/01

A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT04811664 Org: User:
Start: 03/24/21 End: 12/30/21 Due: 12/30/22

Comparing the Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A

Phase: N/A Priority: Normal
NCT ID: NCT02572817 Org: User:
Start: 11/30/15 End: 05/18/18 Due: 05/18/19

Evaluating the Safety and Immunogenicity of a Human Parainfluenza Type 3 (HPIV3) Virus Vaccine in Infants and Children

Phase: N/A Priority: Normal
NCT ID: NCT01254175 Org: User:
Start: 12/31/10 End: 02/29/12 Due: 02/28/13

The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00001070 Org: User:
Start: - End: - Due: -

Study of Mast Cell Precursors

Phase: N/A Priority: Normal
NCT ID: NCT00001756 Org: User:
Start: 12/03/97 End: 11/03/22 Due: 11/03/23

Efficacy and Safety of CR6261 in an H1N1 Influenza Healthy Volunteer Human Challenge Model

Phase: N/A Priority: Normal
NCT ID: NCT02371668 Org: User:
Start: 02/25/15 End: 11/30/18 Due: 11/30/19

Study of Tolerant Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT01338779 Org: User:
Start: 05/31/04 End: 08/31/15 Due: 08/31/16

Tocilizumab (TCZ) in New-onset Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02293837 Org: User:
Start: 03/12/15 End: 08/31/20 Due: 08/31/21

Carotid Artery Thickness in HIV Infected and Uninfected Adults

Phase: N/A Priority: Normal
NCT ID: NCT00007319 Org: User:
Start: - End: - Due: -

Pharmacokinetic Study of IV Artesunate to Treat Children With Severe Malaria

Phase: N/A Priority: Normal
NCT ID: NCT05750459 Org: User:
Start: 11/29/23 End: 04/01/25 Due: 04/01/26

Genetic Factors in Atherosclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00359307 Org: User:
Start: 06/08/00 End: 03/21/13 Due: 03/21/14

Examining the Role of Genetics in Determining the Immune Response to an HIV Vaccine in HIV-Uninfected Adult Twins

Phase: N/A Priority: Normal
NCT ID: NCT01054872 Org: User:
Start: 01/31/10 End: 06/30/16 Due: 06/30/17

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT00004736 Org: User:
Start: - End: - Due: -

Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00063817 Org: User:
Start: 06/30/03 End: 07/31/09 Due: 07/31/10

Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox

Phase: N/A Priority: Normal
NCT ID: NCT00001125 Org: User:
Start: - End: 03/31/04 Due: 03/31/05